• Garcia-Sayan E, Chen T, Khalique OK. Multimodality cardiac imaging for procedural planning and guidance of transcatheter mitral valve replacement and mitral paravalvular leak closure. Front Cardiovasc Med. 2021;8:582925. This paper reviews multimodality cardiac imaging for diagnosis, procedural planning, and intraprocedural guidance of transcatheter mitral valve-in-valve with a balloon-expandable valve, valve-in-ring and valve-in-mitral annular calcification interventions.
Article PubMed PubMed Central Google Scholar
Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22(9):975–1014 quiz 82-4.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.
Sato H, Cavalcante JL, Bae R, Bapat VN, Garcia S, Gössl M, et al. Coaptation reserve predicts optimal reduction in mitral regurgitation and long-term survival with transcatheter edge-to-edge repair. Circ Cardiovasc Interv. 2022;15(7):e011562.
Scotti A, Galasso M, Margonato A, Godino C. Patient selection for trans-catheter mitral valve repair <i>vs</i>. replacement: ongoing indications and glimpse to the future. Vessel Plus. 2021;5:6.
Maurizio T, Francesco M. Challenging mitral clefts with MitraClip: the convergent clips strategy. EuroIntervention. 2016;12(8):e1071.
Ge Y, Gupta S, Fentanes E, Aghayev A, Steigner M, Sobieszczyk P, et al. Role of cardiac CT in pre-procedure planning for transcatheter mitral valve replacement. JACC: Cardiovasc Imaging. 2021;14(8):1571–80.
Modine T, Vahl TP, Khalique OK, Coisne A, Vincent F, Montaigne D, et al. First-in-human implant of the cephea transseptal mitral valve replacement system. Circ Cardiovasc Interv. 2019;12(9):e008003.
Guerrero M, Wang DD, Pursnani A, Eleid M, Khalique O, Urena M, et al. A cardiac computed tomography–based score to categorize mitral annular calcification severity and predict valve embolization. JACC: Cardiovas Imaging. 2020;13(9):1945–57.
Wang DD, Guerrero M, Eng MH, Eleid MF, Meduri CU, Rajagopal V, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC: Cardiovasc Interv. 2019;12(13):1268–79.
Guerrero M, Vemulapalli S, Xiang Q, Wang DD, Eleid M, Cabalka AK, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States. Circ Cardiovasc Interv. 2020;13(3):e008425.
Guerrero M, Urena M, Himbert D, Wang DD, Eleid M, Kodali S, et al. 1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71(17):1841–53.
Gössl M, Thourani V, Babaliaros V, Conradi L, Chehab B, Dumonteil N, Badhwar V, Rizik D, Sun B, Bae R, Guyton R, Chuang M, Blanke P, Sorajja P. Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification. EuroIntervention. 2022;17(18):1523–31. https://doi.org/10.4244/EIJ-D-21-00745.
Article PubMed PubMed Central Google Scholar
Alperi A, Dagenais F, Del Val D, Bernier M, Vahl TP, Khalique OK, et al. Early experience with a novel transfemoral mitral valve implantation system in complex degenerative mitral regurgitation. JACC Cardiovasc Interv. 2020;13(20):2427–37.
Yoon SH, Bleiziffer S, Latib A, Eschenbach L, Ancona M, Vincent F, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2019;12(2):182–93.
Bapat V, Rajagopal V, Meduri C, Farivar RS, Walton A, Duffy SJ, et al. Early Experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71(1):12–21.
• Reid A, Ben Zekry S, Turaga M, Tarazi S, BaxJeroen J, Wang Dee D, et al. Neo-LVOT and transcatheter mitral valve replacement. JACC: Cardiovasc Imaging. 2021;14(4):854–66. This paper is a summary of expert-based recommendations about the risk of LVOT obstruction in different scenarios and the currently available methods to reduce the risk of LVOT obstruction and other post-procedural complications.
Khan JM, Babaliaros VC, Greenbaum AB, Foerst JR, Yazdani S, McCabe JM, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73(20):2521–34.
Article PubMed PubMed Central Google Scholar
Guerrero M, Urena M, Himbert D, Wang DD, Eleid M, Kodali S, et al. 1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71(17):1841–53.
Guerrero M, Wang DD, O’Neill W. Percutaneous rescue of an embolized valve after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2017;10(6):627–9.
Comments (0)